International Congress of Ayurveda: Relief from exploding health costs. The International Congress of Ayurveda, the biggest ever in Europe, brought together 400 participants from 40 countries, including medical doctors, health-administration professionals and three top-ranking representatives of the Indian government. The Congress ended on April 12th in Roermond, Holland after two days of discussing ways in which Ayurveda, the worlds most ancient medical system, can turn back the exploding costs of healthcare through natural treatments and disease prevention.International Congress of Ayurveda

Relief from exploding health costs

 

Roermond, Netherlands (April 11, 2015) – The International Congress of Ayurveda, the biggest ever in Europe, brought together 400 participants from 40 countries, including medical doctors, health-administration professionals and three top-ranking representatives of the Indian government. The Congress ended on April 12th in Roermond, Holland after two days of discussing ways in which Ayurveda, the world’s most ancient medical system, can turn back the exploding costs of healthcare through natural treatments and disease prevention.


Professor Subhash Ranade, leading Ayurvedic expert and co-organizer of the Congress, summed up
its conclusions: “No health system can recognize as early as Ayurveda when the balance of the body is in danger. On this basis we can intervene consultatively and therapeutically, long before difficult-to-treat symptoms appear.”

 

Main organizer of the Congress was the International Maharishi Ayurveda Foundation, with the collaboration of the All India Ayurvedic Congress, the largest Ayurveda organisation worldwide (350,000 members, founded 1907), and with the young International Academy of Ayurveda from Pune, India (founded 1996).

 

 

WHO on lifestyle diseases: “Silent, secret killers”

 

The World Health Organisation (WHO) calls modern lifestyle diseases “silent, secret killers” with 38 million fatalities in 2012 alone. The worldwide economic losses are in the trillions. Prof. Ranade: “Alzheimer’s disease, arthritis, atherosclerosis, asthma, some kinds of cancer, chronic liver disease or cirrhosis, chronic obstructive pulmonary disease, type 2 diabetes, heart disease, metabolic syndrome, chronic renal failure, osteoporosis, stroke, depression and obesity are actually lifestyle diseases.”

 

Dr. med. Ulrich Bauhofer, leading German Ayurvedic doctor and book author, said during his talk: “Modern lifestyle diseases are strangling our healthcare system. Let’s position nature instead – before machines and pills are getting unaffordable. The success of Ayurveda is remarkable and cost-cutting.”

 

Dr. Karin Pirc, medical director of an Ayurvedic clinic in Bad Ems, Germany: “The results of the scientific research on Ayurveda are so promising that we can’t afford to ignore them any longer.”

 

 

Rethinking process

 

Several developments show that this rethinking is going on: In 1996 the Hufeland Society, a German umbrella organisation for naturopathy, evaluated the preventive approach of Ayurveda very positively, not only because of its cost-efficiency, but also because of its scientific character.

 

Some months ago the Indian government established a Ministry for Yoga and Ayurveda. They even suggest the adoption of yoga and meditation as part of teacher training. Last year the German government adopted a draft of a new prevention law. “This is a step in the right direction”, said Dr. Bauhofer. “Prevention must become the new guiding principle of our healthcare policy. Worldwide.”

 

 

Links

 

 

 


International Ayurveda Congress, April 10 – 14, 2015, Roermond, The Netherlands (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…